PTPN6 dampens the oncogenic characteristics of breast cancer by dephosphorylating STAT3 and inactivating the Ras/extracellular signal-regulated kinase (Erk)/glycogen synthase kinase-3beta (GSK-3β) signaling pathway (31, 32). Here, PTPN6 is linked to breast carcinoma.